Removal of serological interference in the treatment of multiple myeloma with CD38 monoclonal antibody using polybrene method

Journal Title: Chinese Journal of Blood Transfusion - Year 2022, Vol 35, Issue 8

Abstract

Objective To investigate the clinical feasibility of polybrene method to remove serological interference in patients receiving anti-CD38 monoclonal antibody for the treatment of multiple myeloma, and its detection performance of alloantibodies. Methods For patients receiving anti-CD38 monoclonal antibody for the treatment of multiple myeloma, unexpected antibody screening and cross-matching blood test were performed by polybrene method. Results The polybrene method can remove the interference of anti-CD38 monoclonal antibodies on blood group serology; both methods can effectively remove anti-CD38 monoclonal antibody to detect anti-E, anti-D, anti-Fya and anti-S antibodies.The titers of anti-D, anti-E, anti-Fya and anti-S alloantibodies, yielded by enhanced polybrene method, were higher than those of the polybrene method.Seven patients received K-antigen-negative blood transfusion without any adverse reactions to blood transfusion. Conclusion For the treatment of multiple myeloma using CD38 monoclonal antibody, the polybrene method can quickly and effectively remove the interference of daratumumab with blood group serology.

Authors and Affiliations

Yan ZHENG, Wenting WANG, Shijie MU, Xia XIE, Qiong WANG

Keywords

Related Articles

Detection and analysis of two drug-induced antibodies in suspicious blood samples from pre-transfusion compatibility tests

Objective To detect the piperacillin and amoxicillin antibodies in suspicious blood samples from pre-transfusion compatibility tests in Wuxi and analyze the general characteristics of them, so as to eliminate the interfe...

Study on platelet components production in 19 provincial blood centers in China before and during the COVID-19 epidemic

Objective To study the changes of platelet components(PC), apheresis platelets (AP) and pooled platelet concentrates (PPC) production of 19 provincial blood centers before and during the COVID-19 epidemic. Methods The da...

Establishment of platelet donor gene bank involving specific antigen HPA 1-6/10/15/21 by real-time fluorescent PCR

Objective To research the genetic polymorphism of HPA 1-6/10/15/21 in platelet donors in Zhongshan area, and establish a gene bank of platelet donors with HPA locus. Methods The HPA 1-6/10/15/21 system genotyping was per...

Therapeutic effect of chemoimmunotherapy on breast cancer sensitized by polymerized human cord hemoglobin in mice: a preliminary study

Objective To investigate the effect of polymerized human cord hemoglobin (PolyCHb) in chemoimmunotherapy for breast cancer in mice. Methods A 4T1 breast cancer in situ tumor model was established, and 15 mice were random...

Effect of IgG dimer concentration on the binding ability of IgG Fc fragment in IVIG to THP-1 cell surface receptors

Objective To investigate the effect of immunoglobulin G (IgG) dimer concentration of intravenous immunoglobulin (IVIG) on the binding ability of IgG Fc fragment to THP-1 cell surface receptors. Methods Firstly, protein p...

Download PDF file
  • EP ID EP738329
  • DOI 10.13303/j.cjbt.issn.1004-549x.2022.08.022
  • Views 33
  • Downloads 0

How To Cite

Yan ZHENG, Wenting WANG, Shijie MU, Xia XIE, Qiong WANG (2022). Removal of serological interference in the treatment of multiple myeloma with CD38 monoclonal antibody using polybrene method. Chinese Journal of Blood Transfusion, 35(8), -. https://europub.co.uk/articles/-A-738329